CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Generate extra income quickly with these effective strategies. Boost your earnings and achieve your financial goals.
21,535 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
A three-brand furniture group projected a budgeted $180 million year, but the Ukraine war pushed the year into the re...
Today’s stock market today, june mood is upbeat as tech outpaces other sectors. Intel’s surge fuels optimism while da...
headlines like Elon Musk Just Lost can spark fear and speculation. This guide breaks down what to watch, how to asse...
Meta Platforms faces a crossroads as AI investments collide with rising costs. Analysts see potential upside toward $...
Vera Bradley faces a pivotal year in 2027. This guide dives into Q1 dynamics, revenue mix, margins, and strategic mov...
Looking to secure the best mortgage rate in 2026? This practical guide breaks down the steps that save you money: sha...
Artificial intelligence is reshaping markets, but one big risk many investors fear may be overblown. This article exp...
The 30-year fixed rate slipped below 6% for the first time since 2022, sparking renewed hope for homebuyers and those...
A new CBO forecast shows tariffs being rolled back would widen the deficit by about $2 trillion over 2026-2036, yet t...
Discover how to read Infinity Natural's earnings calls like a pro. This guide explains the metrics to watch, how mana...
Andersen Group surged on surprise Q4 strength and an optimistic outlook. This deep dive explains what drove the rally...